Blue Pebble Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Blue Pebble Ltd is ₹ 115 as of 20 Mar 15:30 . The P/E Ratio of Blue Pebble Ltd changed from 14 on March 2025 to 14 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Sheel Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Blue Pebble Ltd changed from ₹ 70.99 crore on March 2025 to ₹ 70.99 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Sheel Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The Dividend Payout of Blue Pebble Ltd changed from 4.03 % on March 2025 to 4.03 % on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About Blue Pebble Ltd

Blue Pebble Ltd was originally incorporated as 'Blue Pebble Private Limited' on September 08, 2017 with the Registrar of Companies, Central Registration Centre.
Company converted into a Public Limited and the name was changed to 'Blue Pebble Limited' vide a fresh certificate of incorporation dated October 25, 2023 issued by the Registrar of Companies, Mumbai. Established in 2017, Blue Pebble specialized in spatial design and offers environmental branding solutions.
The Company provide printing and designing services, including theme-based designs, large format printing, vinyl printing, fabric printing, canvas printing, signage manufacturing, and 3D art installation.
It deal in sourcing and installation of curios, sculpture and artisanal hand paintings.
Through their graphics and signage solutions, Company transform workspace into functional environments that align with clients' corporate culture and values.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of Blue Pebble Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, Blue Pebble Ltd or Sheel Biotech Ltd?

Market cap of Blue Pebble Ltd is 46 Cr while Market cap of Sheel Biotech Ltd is 99 Cr

What are the key factors driving the stock performance of Blue Pebble Ltd and Sheel Biotech Ltd?

The stock performance of Blue Pebble Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Blue Pebble Ltd and Sheel Biotech Ltd?

As of March 22, 2026, the Blue Pebble Ltd stock price is INR ₹115.0. On the other hand, Sheel Biotech Ltd stock price is INR ₹49.05.

How do dividend payouts of Blue Pebble Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of Blue Pebble Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.